Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for MNKD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 309.91M
March 31, 2026 308.91M
December 31, 2025 307.83M
September 30, 2025 307.03M
June 30, 2025 306.33M
March 31, 2025 303.92M
December 31, 2024 302.96M
September 30, 2024 275.78M
June 30, 2024 274.47M
March 31, 2024 270.80M
December 31, 2023 270.03M
September 30, 2023 269.54M
June 30, 2023 268.24M
March 31, 2023 264.28M
December 31, 2022 263.79M
September 30, 2022 263.16M
June 30, 2022 257.28M
March 31, 2022 252.41M
December 31, 2021 251.48M
September 30, 2021 250.25M
June 30, 2021 249.62M
March 31, 2021 249.07M
December 31, 2020 242.12M
September 30, 2020 230.92M
June 30, 2020 228.93M
Date Value
March 31, 2020 213.14M
December 31, 2019 211.79M
September 30, 2019 206.41M
June 30, 2019 189.45M
March 31, 2019 187.78M
December 31, 2018 187.03M
September 30, 2018 159.50M
June 30, 2018 145.62M
March 31, 2018 126.01M
December 31, 2017 119.05M
September 30, 2017 104.71M
June 30, 2017 104.62M
March 31, 2017 95.78M
December 31, 2016 95.68M
September 30, 2016 95.67M
June 30, 2016 95.55M
March 31, 2016 85.83M
December 31, 2015 85.73M
September 30, 2015 83.65M
June 30, 2015 82.46M
March 31, 2015 81.82M
December 31, 2014 81.21M
September 30, 2014 81.09M
June 30, 2014 78.81M
March 31, 2014 77.39M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
United Therapeutics Corp. 42.68M
ACADIA Pharmaceuticals, Inc. 172.13M
Gilead Sciences, Inc. 1.241B
Vertex Pharmaceuticals, Inc. 253.35M
Ocugen, Inc. 339.04M